REQUEST A DEMO
Total
USD $0.00
Search more companies

Y.K. Farmasi Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Y.K. Farmasi Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Y.K. Farmasi Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Kota Kinabalu. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on January 18, 1983. In 2021, the company reported a net sales revenue drop of 26.68%. A growth of 43.08% was recorded in its total assets.

Headquarters
Lot 27, Ground Floor, Block D, Iramanis Centre, Jalan Lintas
Kota Kinabalu; Sabah; Postal Code: 88450

Contact Details: Purchase the Y.K. Farmasi Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Y.K. Farmasi Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Y.K. Farmasi Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Y.K. Farmasi Sdn. Bhd. report to view the information.
Incorporation Date:
January 18, 1983
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
60.94%
Purchase this report to view the information.
39.06%
Company Performance
Financial values in the chart are available after Y.K. Farmasi Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-26.68%
Total operating revenue
-26.68%
Operating profit (EBIT)
N/A
EBITDA
-53.07%
Net Profit (Loss) for the Period
N/A
Total assets
43.08%
Total equity
-72.3%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
10608.4%
Quick Ratio
0.19%
Cash Ratio
0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?